BCAB BioAtla, Inc.
-
BioAtla Reported Earnings
Monday, November 16, 2026 · 12:00 AM ET
BioAtla (BCAB) reported a loss of $2.10 per share on revenue of $0.25 million for the . .
ioAtla is a global clinical-stage biotechnology company with operations in San Diego, California, and in Beijing, China through our contractual relationship with BioDuro-Sundia, a provider of preclinical development services.
Earnings Whisper Grade
—
Power Rating—
Reported Earnings
($2.10)
Earnings Whisper®
—
Consensus Estimate
—
Earnings Surprise
Earnings Growth
Reported Revenue
$0.25M
Revenue Estimate
—
Revenue Surprise
Revenue Growth—